Argenx added to Best Ideas List at Wedbush
Wedbush added Argenx (ARGX) to the firm's Best Ideas List as it believes the company is uniquely positioned to deliver sustained, market-leading growth in the autoimmune space, driven by continued expansion of Vyvgart and an emerging pipeline of assets that can sustain long-term momentum. Wedbush has an Outperform rating on the shares with a price target of $715.
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ARGX:
Disclaimer & DisclosureReport an Issue
Argenx pullback brings 'attractive buying opportunity,' says Citi
Argenx Se: Strong Growth Prospects and Attractive Buying Opportunity Amid Vyvgart Expansion and Upcoming Catalysts
Argenx price target lowered to $699 from $701 at Citizens JMP
Argenx upgraded to Outperform from Neutral at Baird
Argenx Se: Buy Rating Affirmed Amid Pricing Strategy Confidence and Promising Growth Prospects
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
L3Harris Technologies price target raised to $270 from $240 at TD Cowen
TD Cowen analyst Gautam Khanna raised the firm's price target on L3Harris Technologies (LHX) to $270 from $240 and keeps a Buy rating on the shares. The firm updated its model as the company's 2026 targets seem more plausible than before as order momentum has shown improvement. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on LHX: Disclaimer & DisclosureReport an Issue L3Harris pays U.S. $62M to settle False Claims Act allegations L3Harris breaks ground on construction of five solid rocket motor facilities Trump Trade: White House announces 'Golden Dome' missile-defense shield Truist says Golden Dome concept selected, Lockheed Martin called out by name L3Harris could rally on Golden Dome briefing, says JPMorgan
Yahoo
an hour ago
- Yahoo
Zscaler price target raised to $300 from $270 at TD Cowen
TD Cowen raised the firm's price target on Zscaler (ZS) to $300 from $270 and keeps a Buy rating on the shares. The firm updated its model as the company's results exceeded F3Q metrics across the board and upped its F4Q. The company is seeing no macro slowdown, its platform approach resonates well with large customers, its pricing scheme (z flex) is positively embraced by customers wishing to expand business with Zscaler, and the acquisition of Red Canary provides an extension into the SOC accelerating agentic AI adoption. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on ZS: Disclaimer & DisclosureReport an Issue Zscaler price target raised to $290 from $275 at Cantor Fitzgerald Zscaler price target raised to $300 from $240 at Wedbush Zscaler price target raised to $304 from $288 at RBC Capital Zscaler price target raised to $290 from $250 at Oppenheimer Zscaler price target raised to $260 from $250 at Loop Capital
Yahoo
an hour ago
- Yahoo
Elastic price target lowered to $110 from $135 at Wedbush
Wedbush analyst Daniel Ives lowered the firm's price target on Elastic (ESTC) to $110 from $135 and keeps an Outperform rating on the shares. The firm notes Elastic delivered its Q4 results featuring strong beats on the top and bottom line, which will be largely overshadowed by FY26 revenue guidance that came in below Street expectations as enterprises are increasingly integrating GenAI into their operations, while the company is seeing more consumption scrutiny due to the murky macro. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ESTC: Disclaimer & DisclosureReport an Issue Elastic price target lowered to $92 from $109 at Cantor Fitzgerald Guggenheim lowers Elastic price target, recommends buying on weakness Elastic price target lowered to $115 from $125 at Baird Elastic price target lowered to $112 from $140 at Stifel Elastic price target lowered to $115 from $120 at Morgan Stanley Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
